Search

everythinglearnresearchcommunity

for

Search:↓

Atopic dermatitis affects the appearance of skin reactions, making certain features more common and improving diagnostic accuracy with dermoscopy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

Skin reactions from cancer treatments might predict how well the treatments work.

Restoring hair follicle immune privilege may help treat alopecia areata.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

The study suggested certain immune cells might cause alopecia areata, but it was retracted.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Immunological treatment improved both neuropathy and alopecia.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Hair follicles in nonsegmental vitiligo are better protected from immune attacks than in alopecia areata.

Topical immunotherapy for alopecia areata may work by creating immune cell clusters in the skin.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Immune therapy for cancer can cause rare hair loss but doesn't stop treatment success.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

Homeopathy might help manage autoimmune diseases.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

IL-1 receptor absence in mice leads to skin cysts and changes in immune response after UVB exposure.

Mogamulizumab can cause hair loss and skin rashes.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

Trichohyalin in hair can trigger immune attacks in alopecia areata.